All In MedTech

Device Trial Radar · NCT05740540

Implant for Walking After Stroke

Customizable Cooperative Multi-joint Control to Enhance Walking Mobility After Stroke

Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

6

Planned (sponsor's estimate)

Start

May 16, 2023

Primary completion

Jun 30, 2027

Study completion Jun 30, 2027

Sponsor

Lead sponsor
MetroHealth Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Case Western Reserve University; Louis Stokes VA Medical Center; Cleveland State University
First posted
Feb 23, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes installing the device and setting the individual up for home use, creating advanced controllers for walking and evaluating the effect of the device over several months.

Conditions

  • Stroke
  • Hemiplegia
  • Gait, Hemiplegic

Interventions

  • IRS-8Device

    Implanted Receiver Stimulator (IRS) delivering 8 channels of stimulation. Appropriate for muscle-based (intramuscular or epimysial) electrodes only

  • IST 12 & IST 16Device

    Implantable Stimulator Telemeter (IST) that provides 12 independent channels of stimulation with the option of 2 channels of bipolar myoelectric signal recording, or 16 independent stimulus channels. Suitable for muscle-based or nerve cuff electrodes such as the CWRU Spiral, Flat Interface Nerve Electrode (FINE) or Composite-Flat Interface Nerve Electrode (C-FINE).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference in Gait speedTime frame: baseline, ~18 weeks post implant, ~44 week post implant

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Louis Stokes Cleveland Veterans Affairs Medical Center

    Cleveland, Ohio

  • MetroHealth Medical Center

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.